glp 1 vs glp2 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Incretin-based therapies in MASLD/MASH: from

In California, new rules that took effect in October 2025 place an affirmative duty on you to verify and document a clinically significant difference for every patient

Sarah's Experience with Semaglutide Starting Treatment: First Doses and Adjustments In November 2022, Sarah began her journey with Semaglutide, starting at a weekly dose of 0.25 mg

What should patients do if theyve been using compounded medications or they cant get their next dose

One of my patients, a 51yearold woman struggling with postmenopausal weight gain and fatigue, had tried countless diets

Funding Statement This research received no external funding

Standards of Medical Care in Diabetes-2018